Balance Sheet
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Ascendis Pharma A (ASND) Shares Outstanding (Weighted Average) (2016 - 2025)

Ascendis Pharma A's Shares Outstanding (Weighted Average) history spans 8 years, with the latest figure at $60.6 million for Q4 2023.

  • For Q4 2023, Shares Outstanding (Weighted Average) rose 5.86% year-over-year to $60.6 million; the TTM value through Dec 2023 reached $60.6 million, up 5.86%, while the annual FY2023 figure was $60.9 million, 3.03% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2023 was $60.6 million at Ascendis Pharma A, up from $57.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $62.7 million in Q4 2021 and bottomed at $51.5 million in Q4 2019.
  • The 5-year median for Shares Outstanding (Weighted Average) is $60.3 million (2020), against an average of $58.5 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) increased 17.23% in 2020 before it dropped 8.7% in 2022.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $51.5 million in 2019, then rose by 17.23% to $60.3 million in 2020, then increased by 3.82% to $62.7 million in 2021, then dropped by 8.7% to $57.2 million in 2022, then grew by 5.86% to $60.6 million in 2023.
  • Per Business Quant, the three most recent readings for ASND's Shares Outstanding (Weighted Average) are $60.6 million (Q4 2023), $57.2 million (Q4 2022), and $62.7 million (Q4 2021).